| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $2.09B | +9.3% |
| Gross profit | $1.51B | — |
| Operating income | $0.37B | — |
| Net income | $0.24B | +30.8% |
| Gross margin | 72.4% | Net margin 11.4% |
| Segment | Revenue | Share |
|---|---|---|
| Knees | $0.83B | 39.7% |
| SET | $0.56B | 26.9% |
| Hips | $0.52B | 25.1% |
| Technology And Data Bone Cement And Surgical | $0.17B | 8.2% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | $0.58B | 27.6% |
| SG&A | $0.85B | 40.7% |
| Tax & other | $0.14B | 6.5% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
ZTS ・ WST ・ WDC ・ WY ・ WSM ・ WMB ・ WTW ・ WDAY ・ WYNN ・ XEL ・ XYL ・ YUM
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies